Toggle navigation
Home
Search
Services
Blog
Contact
About
Rapid Diagnostic for Clostridium Difficile Toxin B
Coughlin, Richard Thomas
Antigenics, Inc., Lexington, MA, United States
Search 15 grants from Richard Coughlin
Search grants from Antigenics, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Systems biology of microbe-mediated glucosinolate bioconversion in inflammatory bowel disease
Lewy body neuropathologies and SNCA gene: variants expression and splicing
Lewy body neuropathologies and SNCA gene: variants expression and splicing
Transcriptional Regulation of Metabolism in Schizophrenia
Racial Differences in Social Relations and Depression
Recently added grants:
Sociobehavioral Sciences Research to Improve Care for HIV Infection in Tanzania
UIC/AJCU Training Program in Advanced Research Methods and Translational Science
Expanded Multidisciplinary NeuroAIDS Research Training to Improve HIV Outcomes in Nigeria
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
Extracellular Vesicle Analyses to Develop Aging and Resilience Biomarkers
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44AI030837-03
Application #
2065921
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1991-09-30
Project End
1996-12-31
Budget Start
1995-09-01
Budget End
1996-12-31
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Institution
Name
Antigenics, Inc.
Department
Type
DUNS #
City
Lexington
State
MA
Country
United States
Zip Code
02421
Related projects
NIH 1995
R44 AI
Rapid Diagnostic for Clostridium Difficile Toxin B
Coughlin, Richard Thomas / Antigenics, Inc.
NIH 1994
R44 AI
Rapid Diagnostic for Clostridium Difficile Toxin B
Coughlin, Richard Thomas / Antigenics, Inc.
Comments
Be the first to comment on Richard Coughlin's grant